PSkarbek

TL3 Regular · Vigo, ES

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 3 November 2024 · last posted 23h · groups: analytical-chemists

139 posts, newest first. Showing up to 150.

[2026 update] Comparing prices across jurisdictions without misleading yourself Replied, post #3 · Access › Pricing · 27 Jul 2026 · 0 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
Follow-up: Reading an interaction checker output critically Replied, post #67 · Practice › Interactions · 26 Jul 2026 · 12 likes Everything in post #63 holds. The case it does not cover is the one I have. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #89 · Meta › Announcements · 24 Jul 2026 · 13 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. What I would tell a new member reading about Trust level 3…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #49 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 27 likes The reason Reading a rodent study keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Shakes versus food: a pragmatic assessment Replied, post #24 · Nutrition & Training › Protein & intake · 15 Jul 2026 · 8 likes Shakes versus food: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
What a certificate commits its issuer to — one year on Replied, post #108 · Analytics › COA interpretation · 13 Jul 2026 · 0 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured.
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #7 · Analytics › COA interpretation · 8 Jul 2026 · 15 likes This follows post #6 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #18 · Clinical › Comorbidities · 2 Jul 2026 · 23 likes I read the earlier replies on Type 2 diabetes twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #80 · Start Here › How to Ask · 28 Jun 2026 · 28 likes Picking up post #79: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Tracking intake honestly when appetite is absent Replied, post #76 · Nutrition & Training › Protein & intake · 27 Jun 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #89 · Safety › Contraindications · 27 Jun 2026 · 12 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. This has been discussed before and I…
Selection into a registry and what it does to the estimate — a second dataset Started this topic · Evidence › Study critique · 25 Jun 2026 · 3 likes Posting this under the heading it deserves: Selection into a registry and what it does to the estimate — a second dataset Everything below is what sits behind that.…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #35 · Sourcing › Independent verification · 22 Jun 2026 · 18 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #52 · Analytics › Impurities & related substances · 20 Jun 2026 · 14 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. An update on my earlier Endotoxin post: the pattern held for another six weeks and…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #79 · Compounds › Semaglutide · 16 Jun 2026 · 6 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Revisiting: The best-written scientific paper you have read Replied, post #33 · Lounge › Off topic · 15 Jun 2026 · 0 likes I disagree with the framing of best-written scientific paper above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so…
Documenting a supplier's response to a discrepancy Replied, post #15 · Sourcing › Vendor reports · 14 Jun 2026 · 14 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
An appeal that succeeded, with the letter structure — the long version Replied, post #92 · Access › Insurance & coverage · 13 Jun 2026 · 11 likes Answering the question post #90 raises rather than the one it answers. Appeal has been discussed here with more heat than it deserves, mostly because two definitions…
Second pass at: Absence of evidence and evidence of absence Replied, post #20 · Research Methods › Statistics · 12 Jun 2026 · 0 likes Taking post #18 at face value and following it one step further. Reporting rather than recommending, on Absence of evidence. What happened is above. Whether it should…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #56 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 1 like On Area percent versus weight percent, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #55 · Compounds › Semaglutide · 8 Jun 2026 · 0 likes Post #53 put the caveat in the right place and I want to underline it. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical…
Gastro-oesophageal reflux: improving or worsening? Replied, post #52 · Clinical › Comorbidities · 4 Jun 2026 · 5 likes Two things can be true about gastro-oesophageal reflux at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
Request: a per-category review queue Replied, post #17 · Meta › Feature requests · 3 Jun 2026 · 18 likes That would also make review dates far more meaningful. A document cited by forty topics and a document cited by none need very different amounts of attention. It took…
Reading a trial's population section before its results Replied, post #80 · Evidence › Trials · 2 Jun 2026 · 3 likes That is a cleaner way of putting what I was circling around.
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #127 · Practice › Storage & stability · 2 Jun 2026 · 13 likes Taking post #124 at face value and following it one step further. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #54 · Devices › Syringes & needles · 28 May 2026 · 1 like Answering the question post #50 raises rather than the one it answers. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #43 · Practice › Storage & stability · 26 May 2026 · 10 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Endotoxin and why it is a separate question from purity — what changed since Replied, post #16 · Analytics › Impurities & related substances · 11 May 2026 · 8 likes Post #15 answers the question as asked. The question underneath it is different. Off-target structures: if the sequence synthesis goes wrong, a completely different…
Reading a trial's population section before its results Replied, post #7 · Evidence › Trials · 8 May 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Reconstitution volumes that produce round numbers, tabulated Replied, post #110 · Practice › Reconstitution · 8 May 2026 · 32 likes This is the first time the answer has come with its own limits attached. Appreciated.
When your prescriber and the evidence disagree Replied, post #11 · Clinical › Prescriber conversations · 4 May 2026 · 23 likes Coming back to post #9, because the follow-up matters more than the original answer. Clarifying indication: if a compound is approved for diabetes but you have obesity…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #11 · Compounds › Semaglutide · 28 Apr 2026 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
[2026 update] Thyroid function tests during substantial weight change Replied, post #48 · Clinical › Bloodwork · 24 Apr 2026 · 24 likes Adding a reference point for Thyroid function tests during substantial. Mine is a single case, collected without controls, and I am posting the method alongside it so…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #30 · Practice › Interactions · 22 Apr 2026 · 15 likes Adding the measurement that post #29 says would settle it. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #41 · Evidence › Trials · 11 Apr 2026 · 12 likes Building on post #39 rather than restating it. I have three months of notes on Subgroup analyses and the honest summary is that the trend is real and the week-to-week…
Grapefruit: why this class is not the class that cares Replied, post #131 · Practice › Interactions · 7 Apr 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Stepping down deliberately, and how to do it without losing progress Replied, post #87 · Practice › Dosing & titration · 6 Apr 2026 · 2 likes Coming back to post #85, because the follow-up matters more than the original answer. Stepping down deliberately: the withdrawal trials show that stopping is followed…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #32 · Evidence › Journal club · 6 Apr 2026 · 1 like Marking my uncertainty on orforglipron phase 2 explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
Journal club: is percentage weight change the right endpoint? Replied, post #35 · Evidence › Journal club · 3 Apr 2026 · 0 likes Building on post #32 rather than restating it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells…
Managing an unplanned gap in supply Replied, post #78 · Access › Shortages · 29 Mar 2026 · 18 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Coming back to: Time to steady state after a dose increase Replied, post #21 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
Cold solution and stinging: the simplest fix Replied, post #10 · Practice › Administration · 24 Mar 2026 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #13 · Evidence › Preprints · 18 Mar 2026 · 26 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
Choosing which test to pay for, given a fixed budget Replied, post #23 · Sourcing › Independent verification · 13 Mar 2026 · 1 like Agreed on all of that, and I have nothing to add to it.
Measurement error in home scales, with a worked standard deviation Replied, post #22 · Research Methods › Statistics · 11 Mar 2026 · 3 likes Whatever the answer on measurement error in home scales turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #55 · Analytics › Mass spectrometry · 3 Mar 2026 · 16 likes Answering the Adducts question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #88 · Evidence › Study critique · 26 Feb 2026 · 7 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #104 · Compounds › Oral incretins · 23 Feb 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
Measurement error in a self-reported exposure Replied, post #29 · Evidence › Study critique · 23 Feb 2026 · 3 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #73 · Sourcing › Vendor reports · 23 Feb 2026 · 14 likes Marking my place. If it changes for me I will come back and say so.
Named, unnamed and unspecified impurities as regulatory categories Replied, post #7 · Analytics › Impurities & related substances · 17 Feb 2026 · 0 likes Taking post #3 at face value and following it one step further. Related substances: compounds chemically related to the target peptide but not the target peptide…
Validating a calculator against hand arithmetic Replied, post #5 · Data & Tools › Calculators · 9 Feb 2026 · 1 like Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
A history of disordered eating: proceeding carefully Replied, post #74 · Wellbeing › Mental health · 26 Jan 2026 · 0 likes On post #70 — agreed on the reasoning, with one qualification. The social side of this — how other people respond to visible change — comes up constantly and has…
The headache that turns out to be dehydration Replied, post #141 · Nutrition & Training › Hydration & electrolytes · 16 Jan 2026 · 0 likes The arithmetic in post #140 is right; the assumption feeding it is the part to check. Rapid correction of a genuine abnormality can be more dangerous than the…
A partial dose because the pen emptied mid-injection Replied, post #11 · Practice › Administration · 7 Jan 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #25 · Regional › UK & Ireland · 31 Dec 2025 · 22 likes Sensible. I would want the same detail before I acted on it either.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #40 · Pharmacology › Pharmacokinetics · 18 Dec 2025 · 1 like I had written a reply contradicting post #36 and deleted it. Here is what survived. Subcutaneous absorption is the rate-limiting step for most of these compounds, which…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #70 · Practice › Interactions · 16 Dec 2025 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
DXA precision and the least significant change for lean mass Replied, post #54 · Outcomes › Body composition · 9 Dec 2025 · 3 likes Picking up post #53: that is the part I would want checked first. Adding the boring version of DXA precision, because the interesting version keeps getting posted and…
Prescription requirements and telehealth models Replied, post #47 · Sourcing › Regulatory · 4 Dec 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #90 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
Freeze-thaw and why one cycle is not the same as five Replied, post #26 · Practice › Storage & stability · 22 Nov 2025 · 30 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
When to stop reading forums, including this one Replied, post #52 · Wellbeing › Mental health · 22 Nov 2025 · 19 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment. Adding a…
High-resolution MS on aggregates and what it can see Replied, post #117 · Analytics › Mass spectrometry · 11 Nov 2025 · 6 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #88 · Sourcing › Vendor reports · 9 Nov 2025 · 1 like Post #85 put the caveat in the right place and I want to underline it. The honest answer on vendor documentation pages is that it depends, and the useful part is the…
Long-time reader, first-time poster Replied, post #3 · Lounge › Introductions · 2 Nov 2025 · 0 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation. Reading it again, the caveat matters more than the…
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 30 Oct 2025 · 2 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
How to ask about something you suspect is a bad idea Replied, post #19 · Start Here › How to Ask · 25 Oct 2025 · 0 likes This follows post #16 rather than contradicting it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you…
Second pass at: Programming during a large energy deficit Replied, post #52 · Nutrition & Training › Resistance training · 24 Oct 2025 · 3 likes Small methodological point on Programming during a large energy: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
Gauge and length selection for subcutaneous injection Replied, post #40 · Devices › Syringes & needles · 16 Oct 2025 · 1 like Small correction to my own earlier position on gauge and length selection. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
New subcategory: rationale and scope Replied, post #20 · Meta › Announcements · 14 Oct 2025 · 2 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #53 · Compounds › Tirzepatide · 12 Oct 2025 · 0 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 13 likes Confirming post #73 from a second method, which matters more than confirming it from a second person. Cagrilintide is a long-acting amylin analogue, which puts it in a…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #108 · Evidence › Preprints · 4 Oct 2025 · 28 likes Everything in post #105 holds. The case it does not cover is the one I have. A preprint that has been up for two years without appearing in a journal is telling you…
Power cut for eleven hours: how I assessed it afterwards Replied, post #81 · Practice › Storage & stability · 3 Oct 2025 · 3 likes Careful with the language on power cut for eleven hours. "Not detected" and "not present" are different findings and the first is a statement about the method.
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #82 · Evidence › Preprints · 2 Oct 2025 · 1 like Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Pinch or no pinch, and how needle length changes the answer Replied, post #88 · Practice › Administration · 1 Oct 2025 · 24 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Reading a supplier's product description as a marketing document Replied, post #75 · Compounds › Other compounds · 25 Sep 2025 · 4 likes I had written a reply contradicting post #73 and deleted it. Here is what survived. Solubility varies far more across this subcategory than within the incretins. A…
Second pass at: Programming during a large energy deficit Replied, post #16 · Nutrition & Training › Resistance training · 23 Sep 2025 · 23 likes Narrowing post #15, because the general version has more than one answer. Adaptation and plateau: if strength does not change for weeks, that is stability, not…
Adolescents: a distinct evidence base — one year on Replied, post #11 · Clinical › Special populations · 24 Aug 2025 · 5 likes On Adolescents, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
Reading a combination trial: attributing effect to components Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 23 Aug 2025 · 24 likes Right, and stated more narrowly than I would have dared to state it.
Are there stupid questions here? A staff answer, at length Replied, post #103 · Start Here › Welcome · 23 Aug 2025 · 13 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds. I…
Titles that describe the question, not the situation Replied, post #71 · Start Here › How to Ask · 14 Aug 2025 · 9 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. Correct me on the…
A preprint whose numbers changed substantially at publication Replied, post #14 · Evidence › Preprints · 9 Aug 2025 · 4 likes Worth separating two things that post #10 runs together. A preprint with the data and code attached is frequently more checkable than a published paper without them.…
An emergency department visit, described afterwards Replied, post #50 · Safety › Adverse events · 5 Aug 2025 · 18 likes Adding a reference point for emergency department visit. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Guidelines revision: what changed and why — one year on Replied, post #5 · Meta › Announcements · 4 Aug 2025 · 0 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
What a documentation review can and cannot tell you Replied, post #58 · Sourcing › Independent verification · 3 Aug 2025 · 29 likes I disagree with the framing of documentation review above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
AOD-9604 and the fragment hypothesis, revisited Replied, post #6 · Compounds › Other compounds · 30 Jul 2025 · 4 likes Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for that form is usually the single most useful document available and is…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #23 · Compounds › Repair & healing peptides · 26 Jul 2025 · 0 likes Where I part company with post #19, and it is a narrow parting. Two claims get bundled together under BPC-157 and they need separating. The descriptive one — this is…
Coming back to: When "no data" is the complete and final answer Replied, post #53 · Compounds › Other compounds · 21 Jul 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Coming back to: Why quantitation is the hard part, not detection Replied, post #33 · Analytics › Home & field testing · 1 Jul 2025 · 1 like Post #31 describes the usual case. This is about the unusual one. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
Trial registration and comparing the protocol with the paper Replied, post #15 · Evidence › Trials · 17 Jun 2025 · 7 likes Checked the trial registration claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Coming back to: Official shortage notices and what they authorise Replied, post #28 · Access › Shortages · 12 Jun 2025 · 6 likes The most useful contribution is a link to the current official notice rather than an account of one pharmacy. I would treat that as a working assumption and revisit it.
Foaming during reconstitution and whether it matters Replied, post #15 · Practice › Reconstitution · 7 Jun 2025 · 8 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Pre-registering a personal experiment, seriously Replied, post #77 · Research Methods › N-of-1 designs · 1 Jun 2025 · 0 likes Duration should be set by how long an effect would take to appear rather than by patience. Stopping early is the commonest reason a personal experiment answers nothing.…
Revisiting: Filter needles: when they help and what they cost you Replied, post #22 · Devices › Syringes & needles · 24 May 2025 · 17 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #112 · Practice › Reconstitution · 21 May 2025 · 17 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Asking about a compound your prescriber has not heard of Replied, post #44 · Clinical › Prescriber conversations · 20 May 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
Holding a dose indefinitely: is there a documented downside? Replied, post #22 · Practice › Dosing & titration · 19 May 2025 · 11 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #54 · Compounds › Tirzepatide · 14 May 2025 · 26 likes Reporting rather than recommending, on GIP component of tirzepatide. What happened is above. Whether it should have is a different question and not one I am qualified…
Validating a calculator against hand arithmetic — what changed since Replied, post #60 · Data & Tools › Calculators · 10 May 2025 · 2 likes Confirming post #57 from a second method, which matters more than confirming it from a second person. A calculator that shows its working is worth ten that give an…
Comparing my trajectory with the trial curves, carefully Started this topic · Outcomes › Progress reports · 23 Apr 2025 · 10 likes Posting this under the heading it deserves: Comparing my trajectory with the trial curves, carefully Everything below is what sits behind that. Maintenance rather than…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #69 · Evidence › Journal club · 20 Apr 2025 · 3 likes Narrowing post #68, because the general version has more than one answer. The figures usually contain the finding and the text usually contains the interpretation.…
Washout: how long is long enough, and for what purpose Replied, post #19 · Pharmacology › Pharmacokinetics · 19 Apr 2025 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
[2026 update] US compounding rules and how they changed Replied, post #8 · Regional › North America · 13 Apr 2025 · 0 likes This follows post #5 rather than contradicting it. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance…
Adjudicated events and why the definition matters — the long version Replied, post #81 · Evidence › Trials · 4 Apr 2025 · 0 likes Post #80 describes the usual case. This is about the unusual one. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
Why cagrilintide alone is discussed so much less than in combination Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 1 like Worth separating two things that post #84 runs together. A definition problem is doing most of the work in this cagrilintide alone discussion. Once the term is pinned…
Reading a supplier's product description as a marketing document Replied, post #9 · Compounds › Other compounds · 1 Apr 2025 · 2 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. Peptides with cyclic or disulphide-constrained structures behave differently on a…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #41 · Sourcing › Vendor reports · 31 Mar 2025 · 18 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Deamidation and the close-eluting pair it produces Replied, post #10 · Analytics › Impurities & related substances · 16 Mar 2025 · 14 likes Adding the measurement that post #9 says would settle it. Before the thread moves on from deamidation — what is the sample size behind the claim? I am not being…
Counter-ion form: the field almost nobody reports — one year on Replied, post #77 · Analytics › COA interpretation · 13 Mar 2025 · 7 likes I read post #73 twice before replying, because I had assumed the opposite. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
Distinguishing a deletion sequence by mass alone Replied, post #93 · Analytics › Mass spectrometry · 16 Feb 2025 · 0 likes Distinguishing a deletion sequence was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #102 · Evidence › Meta-analyses · 12 Feb 2025 · 1 like Narrowing post #99, because the general version has more than one answer. I would keep Random versus fixed effects and the decision it usually gets used for separate in…
[2026 update] Heterogeneity as information rather than as a nuisance Started this topic · Evidence › Meta-analyses · 10 Feb 2025 · 0 likes Heterogeneity as information rather than as a nuisance Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet…
What a seizure notice actually says Replied, post #31 · Sourcing › Logistics · 7 Feb 2025 · 14 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. I looked this up rather than remembered it, which is…
Canadian access and provincial variation Replied, post #55 · Regional › North America · 5 Feb 2025 · 1 like I read post #53 twice before replying, because I had assumed the opposite. Canadian access and provincial variation is worth one more sentence than it usually gets, and…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #40 · Compounds › Oral incretins · 11 Jan 2025 · 21 likes Noted, and I have changed what I was going to do on the strength of it.
Books and papers worth reading that are not about this at all Replied, post #18 · Lounge › Off topic · 9 Jan 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. That is the version I use. It may not be the version that is correct.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #99 · Compounds › Oral incretins · 28 Dec 2024 · 11 likes This is the sort of exchange that makes the archive worth searching.
Journal club: SURMOUNT-1, read without the press release Replied, post #31 · Evidence › Journal club · 21 Dec 2024 · 4 likes SURMOUNT-1 is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Building a sensible monitoring schedule with your prescriber Replied, post #46 · Clinical › Bloodwork · 20 Dec 2024 · 2 likes I came in to disagree and I am leaving without a disagreement.
Injection-site reactions: describing them precisely enough to be useful Replied, post #81 · Practice › Side effects · 17 Dec 2024 · 14 likes Post #79 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
Coming back to: When to suspect the method rather than the sample Replied, post #46 · Analytics › Method validation · 9 Dec 2024 · 0 likes Post #43 is the version of this I will quote in future. One addition. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it…
[2026 update] How to read a forest plot, properly, from scratch Replied, post #20 · Evidence › Trials · 6 Dec 2024 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
[2026 update] New subcategory: rationale and scope Replied, post #27 · Meta › Announcements · 27 Nov 2024 · 2 likes Answering the question post #23 raises rather than the one it answers. The rare case here is the one that costs somebody a week, though, and the common case costs…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #24 · Compounds › Secretagogues & GH axis · 23 Nov 2024 · 3 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. What a well-designed human trial of a secretagogue would look like: randomised,…
Reading a preclinical wound-healing model and its relevance to a human tendon Started this topic · Compounds › Repair & healing peptides · 5 Nov 2024 · 29 likes On the subject in the title: Reading a preclinical wound-healing model and its relevance to a human tendon Working notes rather than a conclusion. Posting a small…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #17 · Sourcing › Regulatory · 27 Oct 2024 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #135 · Clinical › Bloodwork · 23 Oct 2024 · 16 likes Post #133 and I disagree about the size of the effect, not about the direction. The second most useful thing it does is say clearly when the answer is to book the…
Irish differences from the UK position Replied, post #36 · Regional › UK & Ireland · 13 Oct 2024 · 6 likes Careful with the language on irish differences. "Not detected" and "not present" are different findings and the first is a statement about the method.
About the International category Replied, post #11 · Access › International · 10 Oct 2024 · 33 likes Everything in post #9 holds. The case it does not cover is the one I have. Regulatory position dates: a regulatory position is only current as of when it was written.…
About the International category Replied, post #3 · Access › International · 7 Oct 2024 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Progressive overload when the scale is falling — one year on Replied, post #71 · Nutrition & Training › Resistance training · 19 Sep 2024 · 25 likes I changed my mind about Progressive overload after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Circumference measurements as a poor man's composition estimate Replied, post #105 · Outcomes › Body composition · 28 Aug 2024 · 31 likes I had written a reply contradicting post #101 and deleted it. Here is what survived. Neither method is capable of detecting the month-to-month changes that people…
Correlation in a self-tracked dataset: what it can support Replied, post #46 · Research Methods › Statistics · 22 Aug 2024 · 12 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Guidelines revision: what changed and why Replied, post #8 · Meta › Announcements · 24 Jul 2024 · 0 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Marking my uncertainty on guidelines revision explicitly. I am confident about the…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #29 · Compounds › Retatrutide · 17 Jul 2024 · 20 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
Cold packs, phase-change material, and what survives ten days Replied, post #18 · Sourcing › Logistics · 16 Jun 2024 · 6 likes Post #14 put the caveat in the right place and I want to underline it. An observation about cold packs that I cannot explain and am posting anyway, on the principle…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #11 · Practice › Dosing & titration · 10 Jun 2024 · 16 likes Adding a null result on four-week escalation interval. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.